# Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer

> **NCT00719459** · PHASE1 · COMPLETED · sponsor: **Hospira, now a wholly owned subsidiary of Pfizer** · enrollment: 60 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Iron Sucrose
- **DRUG:** Iron Sucrose

## Key facts

- **NCT ID:** NCT00719459
- **Lead sponsor:** Hospira, now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07-13
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719459, "Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00719459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*